Healthcare provider profile · identity verified

Khaled M Rabadi, MD

Nephrology · GRAND FORKS, ND · NPI 1639180425

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Nifedipine Er	Nifedipine	542	111
Losartan Potassium	Losartan Potassium	490	116
Metoprolol Succinate	Metoprolol Succinate	447	113
Amlodipine Besylate	Amlodipine Besylate	385	102
Labetalol Hcl	Labetalol Hcl	371	77
Atorvastatin Calcium	Atorvastatin Calcium	326	69
Simvastatin	Simvastatin	273	60
Omeprazole	Omeprazole	256	58
Levothyroxine Sodium	Levothyroxine Sodium	255	54
Pantoprazole Sodium	Pantoprazole Sodium	187	39
Bumetanide	Bumetanide	183	56
Hydralazine Hcl	Hydralazine Hcl	164	26
Spironolactone	Spironolactone	161	39
Tamsulosin Hcl	Tamsulosin Hcl	161	42
Rosuvastatin Calcium	Rosuvastatin Calcium	151	37
Clopidogrel	Clopidogrel Bisulfate	141	31
Metformin Hcl	Metformin Hcl	134	33
Allopurinol	Allopurinol	129	30
Lisinopril	Lisinopril	125	34
Ozempic	Semaglutide	124	18
Eliquis	Apixaban	118	24
Prednisone	Prednisone	115	27
Sertraline Hcl	Sertraline Hcl	112	25
Prosol	Parenteral Amino Acid 20% No.1	104	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	103	20
Glipizide	Glipizide	96	17
Warfarin Sodium	Warfarin Sodium	94	12
Alendronate Sodium	Alendronate Sodium	93	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	23
Duloxetine Hcl	Duloxetine Hcl	86	15
Carvedilol	Carvedilol	83	17
Novolog Flexpen	Insulin Aspart	80	17
Potassium Chloride	Potassium Chloride	80	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	79	17
Trazodone Hcl	Trazodone Hcl	77	17
Januvia	Sitagliptin Phosphate	72	12
Furosemide	Furosemide	70	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	17
Finasteride	Finasteride	64	12
Hydrochlorothiazide	Hydrochlorothiazide	64	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	15
Humalog Kwikpen U-100	Insulin Lispro	59	17
Citalopram Hbr	Citalopram Hydrobromide	57	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	54	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	25
Gabapentin	Gabapentin	53	21
Metformin Hcl Er	Metformin Hcl	50	14
Entresto	Sacubitril/Valsartan	49	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	48	11
Ezetimibe	Ezetimibe	47	11
Sevelamer Carbonate	Sevelamer Carbonate	45	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	43	13
Nebivolol Hcl	Nebivolol Hcl	43	suppressed
Clonidine Hcl	Clonidine Hcl	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Gemfibrozil	Gemfibrozil	37	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Glipizide Er	Glipizide	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Clinisol	Parenteral Amino Acid 15% No.5	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Lorazepam	Lorazepam	32	17
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Famotidine	Famotidine	31	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Liothyronine Sodium	Liothyronine Sodium	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Jantoven	Warfarin Sodium	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	15
Xarelto	Rivaroxaban	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	26	suppressed
Insulin Aspart Flexpen	Insulin Aspart	25	suppressed
Valsartan	Valsartan	25	suppressed
Torsemide	Torsemide	24	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Azithromycin	Azithromycin	22	21
Meclizine Hcl	Meclizine Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Calcium Acetate	Calcium Acetate	19	suppressed
Estradiol	Estradiol	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	13
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Aliskiren	Aliskiren Hemifumarate	18	suppressed
Alprazolam	Alprazolam	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Febuxostat	Febuxostat	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Amiloride Hcl	Amiloride Hcl	17	suppressed
Atenolol	Atenolol	17	suppressed
Azathioprine	Azathioprine	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Pen Needle	Pen Needle, Diabetic	16	suppressed
Potassium Citrate Er	Potassium Citrate	16	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Linzess	Linaclotide	14	suppressed
Metolazone	Metolazone	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Lactulose	Lactulose	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Quinine Sulfate	Quinine Sulfate	12	suppressed
Sulfasalazine Dr	Sulfasalazine	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nystatin	Nystatin	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error